H1 successfully raises $100 million to widen its healthcare professional data network. Such an amount is successfully achieved in Series C funding. The Series C round was led by Altimeter Capital along with the participation of new investors, Flex Capital, Goldman and Sachs Asset Management and existing investors LeadEdge, Lux Capital, Transformation Capital, Menlo Ventures, and IVP.
Furthermore, as per Crunchbase, it brings the company’s total value raised to roughly around $170 million.
The company has innovated a healthcare professional platform network that will help providers claim their profile and their achievements. Also, it possesses a scholarly and medical claims data library. This New York-based company aims to focus on assisting companies and individuals connect across the healthcare industry. For instance, academic medical centers, hospitals and life science companies adopt the system to find researchers, providers and experts.
“We’ve created a flywheel that spins faster the more HCPs and industry partners engage with our platform and network,” Ariel Katz, co-founder and CEO of H1, said in a statement.
“No other company can match the volume and quality of global healthcare data H1 has, and as a result no one can match the insights we surface. The next phase of our growth will be focused on helping healthcare organizations harness our network for better decision making.”
It also holds a platform for three principal investigators to upload the profiles along with the place to list clinical trial sites. Carevoyance is a platform on the sales side that targets sales for medical device sellers.
The company mentioned that the infusion of cash would be utilized for the purpose of investing in its data and networks. And new cash will be dedicated to hiring and building the products of the company.
H1 solutions include:
Trial landscape: strong global platform to identify principal investigators, clinical trial sites, and profiles for easy access to trial options. The trial landscape will help healthcare providers easily comply with modified FDA guidelines pertaining to patient and physician diversity in the clinical trial.
HCP Universe: It helps the organization to identify and engage healthcare providers from the advisory board member to digital opinion leaders, treatment specialists, and many more.
Explorer: lt is the most comprehensive platform of HCPs that healthcare providers can update and claim their profiles for the purpose of use as digital CV, connect with leaders for clinical trial opportunities, public speaking, and research.
The companies aimed to permit doctors to improve their individual profiles and augment the depth and the value of their proprietary data. H1 customers are among the seven of the top 10 pharmaceutical companies globally and are among several leading academic medical centers.
H1 was founded in 2017, and the company is expected to accelerate its growth next year with a $6 million funding round from its incubator Shore Group.
